News for Protagenic Therapeutics, Inc. (PTIX)

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a significant transaction by acquiring 240,000 shares of Protagenic Therapeutics Inc (

Shares of Coherent Corp. COHR rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results. Coherent rep...

Artelo Biosciences, Inc. (ARTL), a biopharmaceutical company focused on lipid signaling pathway therapies, experienced a 5.45% drop in its stock price. The shar

Galapagos NV (GLPG) experienced a significant stock price increase of 5.17%, reaching $28.29 per share with a trading volume of 302,700 shares and a turnover ra

Capricor Therapeutics, Inc. (CAPR) experienced a notable stock price increase, rising by 5.40%. The stock is currently priced at $20.09 per share with a trading

Curis Inc (CRIS), a biotechnology company, experienced a significant stock price increase of 5.46%. The stock is currently trading at $4.25 per share with a tra

Aileron Therapeutics, Inc. (ALRN), a clinical-stage biopharmaceutical company, experienced a significant stock price increase of 5.27%, reaching $2.70 per share

Protagenic Therapeutics announces $1.275 million stock sale

California-based Tenon Medical, Inc. (TNON), a medical device company is up over 160 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Shares of Champions Oncology, Inc. CSBR rose sharply in today's pre-market trading reported better-than-expected financial results for the first quarter on Wedn...

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit